Active Cancer Genetics & Molecular Biology

Tumour cell death and its fundamental role in establishing a pro-tumourigenic microenvironment

In plain English

AI plain-English summary

Macrophages—immune cells that normally clean up dead cells—can be hijacked by tumours, turning from allies into enablers that fuel cancer growth. This project challenges a long-held belief in cancer biology. Textbooks teach that avoiding cell death is a hallmark of cancer. But the researcher’s earlier work in fruit flies showed that dying tumour cells actually trigger macrophages to gobble up debris in ways that compromise their normal repair functions. Different types of cell death also pose distinct problems for these cleanup cells. The gap is that no one has systematically traced how tumour cell death reshapes the behaviour of macrophages in living tissue, or how this process might undermine cancer treatments. If successful, this work will reveal the fundamental rules governing how cell death and immune clearance interact during tumour growth. That knowledge could eventually help clinicians predict why some therapies fail—because they inadvertently trigger the wrong kind of cell death—and point toward ways to time or combine treatments so that dying tumour cells do not inadvertently recruit macrophages to the tumour’s side. For now, the research is fundamental science. It will not produce a new drug or diagnostic. But understanding this hidden loop between death and immune response could, over time, reshape how we think about treatment resistance.

View original technical description
From the earliest days of our training, biologists are taught that evasion of cell death is a hallmark of cancer. However, it appears that cell death also has a transformative effect on the tumour microenvironment, paradoxically fuelling tumour progression. Furthermore, the pro-tumourigenicity of cell death undercuts the treatment of cancer in the clinic. During my post-doctoral research, I developed advanced biosensors and novel techniques to comprehensively live-image cell death in Drosophila. Using this model, I discovered that macrophages exhibit unrestrained uptake of cellular debris, which can compromise their response to tissue damage. I also revealed that different types of cell death present distinct challenges to the macrophages tasked with clearing them. Here, I will interrogate the fundamental role of cell death during tumourigenesis. I will combine Drosophila’s genetics with in vivo live-imaging, laser-ablation, spatial transcriptomics and mammalian organoid co-culture in order to: 1) Define the contribution of different types of cell death and their clearance to tumourigenesis. 2) Determine how tumour cell death alters the behaviour of tumour-associated macrophages. 3) Interrogate therapy-induced tumour cell death and maximise its efficacy. Ultimately, my aim is to obtain a better fundamental understanding of tumour cell death and leverage this knowledge to improve treatment.

View the original record at the funder ↗

Researchers

Andrew Davidson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

TNF-receptor trafficking and the regulation of inflammation, cell death and cancer
Harnessing necrosis to enhance anti-tumourigenic cell death and inflammation
Investigating non-professional efferocytosis through two new, in vivo models
Detecting Death and Damage in vivo; Using Drosophila to Understand Innate Immune Cell Priming
Find-me and eat-me: understanding how signals from dying cells control and subvert macrophage behaviour

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.